Discover 3,591 paid clinical trials in Fullerton, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,591
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Fullerton CA, Orange CA, Los Alamitos CA, Whittier CA,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT03907046
Phase 3, Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Location: Fullerton CA, Grand Junction CO, Golden CO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06758401
Phase 3, Recruiting
Stool Sample Collection Study
for
Colorectal Cancer
Location: Anaheim CA, Cordova TN, Ocala FL
Sponsor: Innovis LLC
Sex: All
Age: 18+
Code: NCT06294873
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Fullerton CA, Whittier CA, Duarte CA, Irvine CA,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase 3, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Fullerton CA, Orange CA, Irvine CA, Newport Beach CA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Fullerton CA, Los Angeles CA, San Francisco CA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06203210
Phase 3, Recruiting
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer (NSCLC),
Location: Fullerton CA, Orange CA, Edwards CO, Dallas TX,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07140016
Phase 1, Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Fullerton CA, Los Alamitos CA, Long Beach CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
for
Small Cell Lung Cancer, Advanced Solid Malignant Tumor
Location: Fullerton CA, Encinitas CA, Las Vegas NV,
Sponsor: Chipscreen Biosciences, Ltd.
Sex: All
Age: 18+
Code: NCT05271292
Phase 1, Phase 2, Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Fullerton CA, Pasadena CA, Oxnard CA, Poway CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase 2, Phase 3, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Location: Fullerton CA, Long Beach CA, Pasadena CA,
Sponsor: Amgen
Sex: All
Age: 50+
Code: NCT07614776
Phase 3, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Fullerton CA, Santa Ana CA, Huntington Beach CA,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase 2, Recruiting
High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
for
Diabetic Macular Edema (DME)
Location: Fullerton CA
Sponsor: Retina Consultants of Orange County
Sex: All
Age: 21+
Code: NCT06662994
Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration